Variant report
Variant | esv3355735 |
---|---|
Chromosome Location | chr15:50698862-50699323 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:6)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:6 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr15:50697624..50699517-chr15:50704069..50705762,2 | K562 | blood: | |
2 | chr15:50699305..50701838-chr15:50704277..50706239,2 | MCF-7 | breast: | |
3 | chr15:50696545..50700868-chr15:50714875..50717692,5 | MCF-7 | breast: | |
4 | chr15:50696757..50701800-chr15:50711495..50716438,5 | K562 | blood: | |
5 | chr15:50691142..50692754-chr15:50698415..50700723,2 | MCF-7 | breast: | |
6 | chr15:50697447..50700714-chr15:50702324..50705855,6 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000138592 | chromatin interactions |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs553091335 | chr15:50698874-50698875 | Weak transcription Enhancers Bivalent Enhancer | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs368937597 | chr15:50698875-50698876 | Weak transcription Enhancers Bivalent Enhancer | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs57009320 | chr15:50698876-50698877 | Weak transcription Enhancers Bivalent Enhancer | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs558629103 | chr15:50698973-50698974 | Weak transcription Enhancers Bivalent Enhancer | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs140265371 | chr15:50698995-50698996 | Weak transcription Enhancers Bivalent Enhancer | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs549560684 | chr15:50699022-50699023 | Weak transcription Enhancers Bivalent Enhancer | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs530847569 | chr15:50699039-50699040 | Weak transcription Enhancers Bivalent Enhancer | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs142563299 | chr15:50699040-50699041 | Weak transcription Enhancers Bivalent Enhancer | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs565309392 | chr15:50699097-50699098 | Weak transcription Enhancers Bivalent Enhancer | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs532355791 | chr15:50699133-50699134 | Weak transcription Enhancers Bivalent Enhancer | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs547525134 | chr15:50699153-50699154 | Weak transcription Enhancers Bivalent Enhancer | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs565831706 | chr15:50699154-50699155 | Weak transcription Enhancers Bivalent Enhancer | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs377124205 | chr15:50699225-50699226 | Weak transcription Enhancers Bivalent Enhancer | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs576569596 | chr15:50699250-50699251 | Weak transcription Enhancers Bivalent Enhancer | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs548774894 | chr15:50699271-50699272 | Weak transcription Enhancers Bivalent Enhancer | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs28758306 | chr15:50699276-50699277 | Weak transcription Enhancers Bivalent Enhancer | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs537770400 | chr15:50699289-50699290 | Weak transcription Enhancers Bivalent Enhancer | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs7359315 | chr15:50699304-50699305 | Weak transcription Enhancers Bivalent Enhancer | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Ewing''s sarcoma | 21437220 | CNVD |
Schizophrenia | 19415332 | CNVD |
Breast cancer | 22522925 | CNVD |
Autism | 22495311 | CNVD |
Wilms tumour | 21544195 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
cataract | 16735990 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Medulloblastoma | 21979893 | CNVD |
spastic paraplegia with thinning of corpus callosum | 19105190 | CNVD |
Schizophrenia | 21324950 | CNVD |
Astrocytoma | 17387387 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Disease | 21824424 | CNVD |
Melanoma | 18172304 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Gastric cancer | 17167181 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Intellectual disability | 22102821 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Prostate cancer | 16573809 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Lung cancer | 18438408 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 21785460 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Prostate cancer | 18632612 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Breast cancer | 22032731 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Cancer | 21129771 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Abnormal phenotypes | 18644119 | CNVD |
Cancer | 16751803 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Breast cancer | 21364760 | CNVD |
Amyotrophic lateral sclerosis | 20685689 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr15:50683800-50703800 | Weak transcription | K562 | blood |
2 | chr15:50686800-50699400 | Weak transcription | H9 Cell Line | embryonic stem cell |
3 | chr15:50697000-50699200 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
4 | chr15:50697200-50699400 | Enhancers | Monocytes-CD14+_RO01746 | blood |
5 | chr15:50697200-50699600 | Enhancers | Primary monocytes fromperipheralblood | blood |
6 | chr15:50697600-50699800 | Enhancers | Primary neutrophils fromperipheralblood | blood |
7 | chr15:50698200-50715800 | Weak transcription | Primary T cells from cord blood | blood |
8 | chr15:50698800-50699600 | Bivalent Enhancer | HepG2 | liver |